Atul Verma

Dr. Atul Verma is a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) at the Montreal General Hospital site, where he is affiliated with the Cardiovascular Health Across the Lifespan Program and the Centre for Outcomes Research and Evaluation. He serves as an Associate Professor in the Department of Medicine within the Faculty of Medicine and Health Sciences at McGill University. His work bridges clinical practice and research in cardiac electrophysiology, with a focus on innovative treatments for heart rhythm disorders.

Dr. Verma is a cardiologist and cardiac electrophysiologist specializing in heart rhythm disturbances called arrhythmias. His research primarily focuses on interventional solutions for treating arrhythmias, including pacemaker or defibrillator implantation and catheter ablation. He is actively involved in several clinical trials investigating new techniques and technologies for catheter ablation of atrial fibrillation and ventricular tachycardia. His translational laboratory work evaluates emerging ablation technologies such as pulsed field ablation, ultra-low temperature cryoablation, and needle ablation.

Dr. Verma's recent research has centered on advancing pulsed field ablation techniques for atrial fibrillation treatment. His work spans from basic laboratory investigations to large multicenter clinical trials, including the PULSED AF, ADVANTAGE AF, and inspIRE trials. His research explores personalized approaches to ablation, incorporating artificial intelligence and novel mapping techniques to improve outcomes, particularly for persistent atrial fibrillation cases where conventional approaches have limitations.

Dr. Verma has made significant contributions to the field through numerous high-impact publications in leading journals including the New England Journal of Medicine, JAMA, and Circulation. His research has significantly influenced clinical practice guidelines for atrial fibrillation management.

As a Senior Scientist at RI-MUHC, Dr. Verma leads a research team focused on translational cardiac electrophysiology. His laboratory investigates novel ablation technologies and their mechanisms of action, working closely with clinical teams to rapidly translate findings into patient care. He collaborates extensively with international research groups on multicenter clinical trials evaluating new arrhythmia treatments.